Skip to main content

Back to Cancer Australia's website

Australian Government - Cancer Australia
Home

Search form

EdCaN - learning resources for nurses

  • EdCaN learning resources
  • Professional development
  • About EdCaN
  • Contact us

Search form

  • Alkylating agents
  • Antimetabolites
  • Antitumour antibiotics
  • Plant alkaloids
  • Miscellaneous agents
  • Hormonal agents
  1. EdCaN learning resources
  2. Supporting resources
  3. Antineoplastic agents
  4. Classification
  5. Miscellaneous agents
  • Printer-friendly version
  • A|A

Miscellaneous agents

  • Using the EdCaN resources
  • Case-based learning resources
  • Supporting resources
    • The cancer journey
    • Population health concepts
    • The biology of cancer
    • Cancer treatment planning
    • Surgery
    • Radiotherapy
    • Antineoplastic agents
      • Overview
      • Role of antineoplastics
      • Key concepts
      • Classification
      • Selection and administration
      • Administration principles
      • Models of care
      • Responses
      • Toxicity grading scales
      • References
    • Targeted therapies
    • Stem cell transplantation
    • Supportive care
    • Aboriginal and Torres Strait Islander peoples
  • Entry to specialty program
  • Alkylating agents
  • Antimetabolites
  • Antitumour antibiotics
  • Plant alkaloids
  • Miscellaneous agents
  • Hormonal agents

Miscellaneous agents differ from any of the major classes of cytotoxic agents. 
Common miscellaneous agents are asparaginase and hydroxyurea.1, 7, 11

Topoisomerase inhibitors prevent realigning of DNA strands and maintain single-strand breaks. Major toxicities occur in the haematopoietic and gastrointestinal systems. Examples include irinotecan and topotecan.1, 7, 11

Learning activity

Choose a miscellaneous agent and discuss the:

  • Indications in cancer control.
  • Mechanism of action.
  • Adverse effects.
  • Administration considerations.

Next: Hormonal agents

  • Copyright © 2023 - Cancer Australia
  • Contact Us
  • Copyright
  • Disclaimer
  • Privacy policy